Three perspectives converged today on the same point: synthetic data is moving from a niche ML tool to a governance instrument. A regulator, a public health institution, and a legal commentary each frame synthetic data as a practical way to reduce privacy and access constraints while still enabling model development.
Synthetic Data (EDPS TechSonar)
The European Data Protection Supervisor (EDPS) published an overview of synthetic data as a technique to support machine learning by providing labeled training data without the same usage restrictions as many real-world datasets. EDPS highlights applications including transfer learning and software testing, and positions synthetic data as a response to two recurring constraints for AI teams: the cost of building and maintaining data repositories and the privacy limits that restrict reuse of personal data in model development.
From a governance standpoint, the framing matters: EDPS treats synthetic data not only as an engineering workaround, but as a privacy-preserving approach that can better align AI development with EU accountability and compliance expectations.
- Regulatory signal: When a DPA-level body treats synthetic data as a legitimate tool for privacy-preserving AI, it strengthens the case for including it in DPIAs, AI risk assessments, and data access policies.
- Practical enablement: Labeled synthetic datasets can reduce dependence on restricted real data for training, transfer learning, and testing—especially where access approvals are the bottleneck.
- Documentation pressure: The compliance value will hinge on how teams document generation methods, intended use, and residual re-identification risk—synthetic is not automatically “non-personal.”
Synthetic data allows for safe sharing in low-resource settings (NIH)
NIH’s Fogarty International Center described how synthetic data can enable safer medical data sharing in low-resource settings, citing work in places such as Kenya. The piece explains that synthetic datasets aim to replicate the statistical properties of the original data while presenting minimal privacy risks, enabling collaboration and AI research without exposing patient records. It also references the use of GAN-based approaches such as CTGAN to target higher fidelity, utility, and protection.
The message is operational: synthetic data can be a mechanism to unblock legitimate research and model development when privacy rules, consent limitations, or cross-border sharing constraints make direct access to clinical data difficult.
- Access strategy for health AI: For teams facing strict patient privacy requirements, synthetic data can provide a governed “shareable layer” for model prototyping and external collaboration.
- Equity and coverage: If executed well, synthetic generation can help expand training data availability in settings where data infrastructure and sharing agreements are limited—supporting broader representation in health models.
- Validation becomes the product: Claims of “minimal privacy risk” require measurable tests (utility and privacy evaluation), plus controls on who can generate, tune, and distribute the synthetic outputs.
Synthetic Data: The Hidden Lever Behind Responsible AI Strategy (Criminal Law Library Blog)
A legal-focused blog post argues that synthetic data can function as a core lever in “responsible AI” programs by enabling model training without common legal exposures tied to real datasets—privacy violations, copyright issues, and certain bias risks. It also frames synthetic data as a way to implement “fairness by design,” reducing downstream legal and governance risk when datasets are created intentionally rather than collected opportunistically.
While the article is not a regulator or standards body, it reflects how legal stakeholders are increasingly treating dataset provenance and rights management as first-order AI risks, not secondary compliance tasks.
- Broader risk surface: Synthetic data is being positioned as a mitigation not just for privacy, but also for IP and bias-related governance—bringing legal, compliance, and ML teams into the same design conversation.
- Governance expectations rise: If synthetic data is used to argue reduced legal exposure, teams should be ready to show traceable generation workflows, testing results, and clear limits on what the synthetic data represents.
- “Fairness by design” needs proof: Synthetic data can reduce or reshape bias, but it can also reproduce it; governance programs will need explicit bias evaluation rather than relying on the label “synthetic.”